At Novartis Diagnostics we provide diagnostic tools that make a difference and improve the quality of human life. Novartis Diagnostics is transforming the landscape of disease prevention, diagnosis, monitoring and treatment through our Chiron line of blood testing products and our advanced molecular science. We are discovering smarter, faster technologies to ensure safer blood supplies around the world. And, we are leading the development of predictive, personalized medicine through molecular diagnostics.

 

Our blood testing products  

In 1986, Chiron scientists first identified the hepatitis C virus leading to the development of the first test to screen blood for HCV. Since then, Novartis Diagnostics is proud to build upon the Chiron legacy in protecting the world’s blood supply through our Chiron line of blood testing products.

Our Chiron PROCLEIX® Assays and Systems incorporate state-of-the-art nucleic acid testing (NAT) technology developed by Gen-Probe Incorporated to detect viral RNA and DNA in donated blood, plasma, organs and tissue. By identifying infectious agents during the very early stages of infection, our blood testing products help blood centers worldwide prevent transfusion-related infections. To learn more about our Chiron blood testing products, go to www.chiron.com.

This year, San Jose Magazine named Novartis Diagnostics on its Top 40 list of the '2008 Best Places to Work in Northern California.'

Watch the video

Novartis was named one of the most ethical companies See the article See the article Read more about Integrity and Compliance

About Novartis

Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance the quality of life.

more